02/22/2026
As semaglutide and other GLP-1 therapies continue to support significant weight-loss outcomes, aesthetic practitioners see a new challenge emerge: facial volume loss and changes in skin quality, often referred to as the “Ozempic face.”
Unlike traditional aging, these changes can appear rapidly and disproportionately, leaving patients looking tired or drawn despite improved overall health.
At Maylips, we support a skin-quality-first approach to treatment. Careful assessment, patient education, and staged correction strategies help practitioners safely and effectively address accelerated structural change. 👌
By combining deep structural support, skin-quality optimization, and micro-dosed injectables, you can restore balance and facial harmony while respecting ongoing metabolic changes.
Visit our blog section https://bitly.cx/U3XR to learn more about this important topic.